Exosomes activate hippocampal microglia in atrial fibrillation through long-distance heart-brain communication

• Published in: BMC cardiovascular disorders 2024-11, Vol.24 (1), p.627-15, Article 627
• Main Authors: Wang, Xuewen, Ke, Yuanjia, Cao, Zhen, Fu, Yuntao, Cheng, Yanni, Liu, Dishiwen, Chen, Huiyu, Guo, Kexin, Li, Yajia, Yang, Mei, Zhao, Qingyan
• Format: Article
• Language: English
• Subjects: Adenoviruses; Adipose tissue; Alzheimer's disease; Analysis; Animals; Atrial fibrillation; Atrial Fibrillation - etiology; Atrial Fibrillation - metabolism; Atrial Fibrillation - physiopathology; Benzylidene Compounds - pharmacology; Brain research; Canine; Cardiac arrhythmia; Cardiac Pacing, Artificial; Care and treatment; CD63 antigen; CD81 antigen; Cell activation; Cell Communication; Cognition disorders; Cognitive ability; Cognitive Dysfunction - etiology; Cognitive Dysfunction - metabolism; Cognitive impairment; Complications and side effects; Dementia disorders; Disease Models, Animal; Dogs; Endothelial cells; Exosomes; Exosomes - metabolism; Fibrillation; Genetic aspects; Heart Rate; Hippocampus; Hippocampus - metabolism; Immunofluorescence; Laboratory animals; Male; Microglia; Microglia - metabolism; Microglia - pathology; MicroRNAs; MicroRNAs - genetics; MicroRNAs - metabolism; Microvasculature; miRNA; mRNA; Pacemakers; Polymerase chain reaction; Prevention; Proteins; Risk factors; RNA sequencing; Signal Transduction; Ultracentrifugation
• ISSN: 1471-2261; 1471-2261
• DOI: 10.1186/s12872-024-04274-3

There is growing evidence that atrial fibrillation (AF) is a risk factor for cognitive impairment (CI) and dementia in the presence or absence of stroke. The purpose of this study was to explore the mechanism of CI caused by AF. Eighteen male canines were randomly divided into a sham group, a pacing group, and a pacing + GW4869 group. An experimental model of AF was established by rapid atrial pacing (450 beats/min) for 2 weeks, and the sham group received pacemaker implantation without atrial pacing. The GW4869 group received an intravenous GW4869 injection (0.3 mg/kg, once a day) during pacing. All canines were locally injected with Ad-CD63-RFP in epicardial adipose tissue (EAT) to trace the exosomes. Ultracentrifugation was employed to isolate EAT-derived exosomes, followed by RNA sequencing and quantitative real-time PCR (qRT-PCR) to assess RNA in both exosomes and hippocampal tissue. The miRanda database was used to predict the targeting relationships between miRNA and mRNA, which were further validated by luciferase reporter assays. Western blot analysis was conducted to detect exosomal markers (CD63, CD81, TSG101) in EAT exosomes, while immunofluorescence was used to detect Ad-CD63-RFP signals in both EAT and hippocampal tissues, as well as microglial activation marker IBA-1. To further explore the effects of exosomes on microglial cells, in vitro experiments using brain microvascular endothelial cells (bEnd3) and microglial cells (BV2) were conducted. IBA-1 expression and RNA levels in BV2 cells were analyzed by immunofluorescence and qRT-PCR, respectively. After 14 days of pacing of the canine atrium, compared to the sham group, both the pacing and GW4869 groups exhibited an increased number of AF inductions, along with prolonged AF duration. The fluorescence intensity of Ad-CD63-RFP and the microglial activation marker IBA-1 were markedly greater in the hippocampus. RNA sequencing showed that the differentially expressed gene cfa-miR-22e in EAT exosomes was upregulated, and its target gene IL33 was downregulated in the hippocampus. qRT-PCR showed that the levels of cfa-miR-22e were increased in both EAT exosomes and the hippocampus, while the expression of IL-33, a target of cfa-miR-22e, was decreased in the hippocampus. The administration of GW4869 abolished these effects. The in vitro results from bEnd3 and BV2 cell experiments were consistent with the conclusions drawn from the in vivo studies. Our study indicated that the exosomes secreted by